One laser session may be as safe as four for diabetic eyes

NCT ID NCT01766362

Completed Disease control Sponsor: Centre Hospitalier Universitaire Dijon Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 83 people with diabetes and early-stage eye disease. It compared having laser treatment in one session versus four sessions to see which approach better controls the disease and reduces the risk of swelling in the center of the eye. The main goal was to measure the thickness of the central retina 9 months after treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES TYPE 1 OR 2 WITH DIABETIC RETINOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic retinopathy type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES TYPE 1 OR 2 WITH DIABETIC RETINOPATHY

Contacts and locations

Locations

CHU Dijon

Dijon, 21000, France
CHU de la Croix Rousse

Lyon, 69004, France
Hôpital Lariboisière

Paris, 75475, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.